Health ❯ Healthcare ❯ Medical Research ❯ Neurology

Alzheimer's Disease

3-Minute At-Home EEG ‘Fastball’ Flags Alzheimer’s-Linked Memory Impairment

A peer-reviewed study of 106 people found the passive test detected amnestic mild cognitive impairment in home settings, with larger biomarker-based validations now under way.

24 ARTICLES

2mo ago

Low-Dose Lithium Orotate Reverses Alzheimer’s in Mice, Researchers Call for Human Trials

4 ARTICLES

3mo ago

Four-Year Lecanemab Study Shows Growing Cognitive Benefits and Stable Safety

8 ARTICLES

3mo ago

Novel Alzheimer’s Antibody Moves to Phase III After 90% Plaque Clearance

5 ARTICLES

3mo ago

Wake Forest Plans Expanded Trials After PET Study Validates Intranasal Insulin Delivery

10 ARTICLES

3mo ago

Cancer Drugs Reverse Alzheimer’s Pathology in Mice, Advance to Clinical Trials

3 ARTICLES

3mo ago

AI Stratification Uncovers Alzheimer’s Drug Efficacy, Drives NHS Toward Precision Trials

3 ARTICLES

3mo ago

Alzheimer’s Drug Trials Surge 11% in 2025 as NICE Reviews Lecanemab and Donanemab

4 ARTICLES

5mo ago

Study Finds Alzheimer’s Risk Disclosure Reduces Anxiety but Dampens Motivation for Healthy Habits

5 ARTICLES

6mo ago

Living Human Brain Tissue Provides Breakthrough Insights Into Alzheimer’s Disease

24 ARTICLES

7mo ago

Shingles Vaccine Linked to 20% Dementia Risk Reduction in Landmark Study

6 ARTICLES

7mo ago

Blood Test Advances Alzheimer’s Diagnosis and Staging with 92% Accuracy

5 ARTICLES

7mo ago

Breakthrough Blood Test for Alzheimer’s Diagnoses Disease and Tracks Progression

8 ARTICLES

7mo ago

Study Suggests Long-Term Anti-Amyloid Therapy May Delay Early-Onset Alzheimer’s

21 ARTICLES

11mo ago

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

6 ARTICLES

last yr.

Dopamine Shows Promise in Reducing Alzheimer's Plaques

4 ARTICLES

last yr.

New Alzheimer's Drugs Face Scrutiny Over Efficacy and Safety

Alzheimer's Disease

3-Minute At-Home EEG ‘Fastball’ Flags Alzheimer’s-Linked Memory Impairment

Low-Dose Lithium Orotate Reverses Alzheimer’s in Mice, Researchers Call for Human Trials

Four-Year Lecanemab Study Shows Growing Cognitive Benefits and Stable Safety

Novel Alzheimer’s Antibody Moves to Phase III After 90% Plaque Clearance

Wake Forest Plans Expanded Trials After PET Study Validates Intranasal Insulin Delivery

Cancer Drugs Reverse Alzheimer’s Pathology in Mice, Advance to Clinical Trials

AI Stratification Uncovers Alzheimer’s Drug Efficacy, Drives NHS Toward Precision Trials

UNM Launches Phase 1a/1b Trial of Tau-Targeting Alzheimer’s Vaccine

Four Distinct Alzheimer’s Progression Pathways Validated in Diverse Cohorts

FDA Approves 95% Sensitive Blood Test for Alzheimer’s

Never miss stories about

Alzheimer's Disease

Alzheimer’s Drug Trials Surge 11% in 2025 as NICE Reviews Lecanemab and Donanemab

Study Finds Alzheimer’s Risk Disclosure Reduces Anxiety but Dampens Motivation for Healthy Habits

Living Human Brain Tissue Provides Breakthrough Insights Into Alzheimer’s Disease

Shingles Vaccine Linked to 20% Dementia Risk Reduction in Landmark Study

Blood Test Advances Alzheimer’s Diagnosis and Staging with 92% Accuracy

Breakthrough Blood Test for Alzheimer’s Diagnoses Disease and Tracks Progression

Study Suggests Long-Term Anti-Amyloid Therapy May Delay Early-Onset Alzheimer’s

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

Dopamine Shows Promise in Reducing Alzheimer's Plaques

New Alzheimer's Drugs Face Scrutiny Over Efficacy and Safety

Never miss stories about

Alzheimer's Disease